# US 2021/0002633 A1 · Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0002633 A1
- Document ID: US20210002633A1
- Status: Published application
- Kind: A1
- Application number: 16/992,595
- Filed: 2020-08-13
- Published: 2021-01-07
- Earliest claimed: 2013-10-17
- Assignees: Takara Bio USA, Inc.
- Applicants: Takara Bio USA, Inc.
- Inventors: Craig Betts; Steve Oh; George G. Jokhadze; Nathalie Bolduc
- Web page: https://patentgrep.com/patent/US20210002633A1

## CPC

- C12N 15/1068: {Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis}
- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12Q 1/6853: using modified primers or templates
- C12Y 207/07007: DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
- C12Y 207/07049: RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES

## Abstract

Provided are methods of adding adapters to nucleic acids. The methods include combining in a reaction mixture a template ribonucleic acid (RNA), a template switch oligonucleotide including a 3′ hybridization domain and a sequencing platform adapter construct, a polymerase, and dNTPs. The reaction mixture components are combined under conditions sufficient to produce a product nucleic acid that includes the template RNA and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid that includes a region polymerized from the dNTPs by the polymerase. Aspects of the invention further include compositions and kits.

## Claims

### Claim at position 1

1-45. (canceled)

### Claim 46

A method comprising:
(a) providing a precursor ribonucleic acid (RNA);
(b) adding a plurality of non-templated nucleotides to an end of the precursor RNA to produce a template RNA;
(c) combining:
the template RNA;
a template switch oligonucleotide (TSO) comprising a first nucleotide sequence domain;
a polymerase having terminal transferase activity;
a first strand primer comprising a first domain that hybridizes to the non-templated nucleotides in the template RNA and a second domain having a nucleotide sequence that is different from the first nucleotide sequence domain present in the TSO; and
dNTPs;
in a reaction mixture under conditions sufficient to produce a product nucleic acid comprising the template RNA and the TSO hybridized to adjacent regions of a single product nucleic acid comprising the first strand primer and a region polymerized from the dNTPs by the polymerase; and
(d) amplifying the product nucleic acid with a forward primer and a reverse primer,
wherein each of the forward primer and the reverse primer comprises a sequencing platform adapter construct comprising at least a portion of a capture sequence that is utilized by a sequencing platform,
wherein the capture sequence specifically hybridizes to a surface-attached sequencing platform oligonucleotide on the sequencing platform, and
wherein the forward and reverse primers are different and hybridize to different sequences of the product nucleic acid.

### Claim 47 (depends on 46)

The method according to claim 46, further comprising sequencing the amplified product nucleic acid by the sequencing platform that comprises the surface-attached sequencing platform oligonucleotide that captures the at least portion of the capture sequence of the sequencing platform adapter construct.

### Claim 48 (depends on 46)

The method according to claim 46, wherein the non-templated nucleotides are added to the 3′ end of the precursor RNA.

### Claim 49 (depends on 46)

The method according to claim 46, wherein the non-templated nucleotides are added in an enzymatic reaction.

### Claim 50 (depends on 46)

The method according to claim 46, wherein the non-templated nucleotides comprise a polyadenylation (poly A) sequence.

### Claim 51 (depends on 46)

The method according to claim 46, wherein the precursor RNA is a non-polyadenylated RNA.

### Claim 52 (depends on 51)

The method according to claim 51, wherein the non-polyadenylated RNA is selected from the group consisting of a microRNA, a siRNA, and a small RNA.

### Claim 53 (depends on 46)

The method according to claim 46, wherein the polymerase is a reverse transcriptase.

### Claim 54 (depends on 46)

The method according to claim 46, wherein the template switch oligonucleotide, the first strand primer, or both the template switch oligonucleotide and the first strand primer comprise a sequencing platform adapter construct that is utilized by a sequencing platform.

### Claim 55 (depends on 54)

The method according to claim 54, wherein the sequencing platform adapter construct comprises a nucleic acid domain selected from the group consisting of: a domain that specifically hybridizes to the surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, and combinations thereof.

### Claim 56

A kit, the kit comprising:
a) a template switch oligonucleotide (TSO) comprising a 3′ hybridization domain;
b) a first polymerase;
c) a first strand primer comprising a first domain that hybridizes to a template RNA;
d) dNTPs; and
e) a second polymerase.

### Claim 57 (depends on 56)

The kit according to claim 56, wherein the first polymerase further comprises terminal transferase activity and template switching activity

### Claim 58 (depends on 56)

The kit according to claim 56, wherein the first polymerase is a reverse transcriptase.

### Claim 59 (depends on 58)

The kit according to claim 58, wherein the reverse transcriptase is a MMLV reverse transcriptase.

### Claim 60 (depends on 56)

The kit according to claim 56, wherein the second polymerase adds dNTPs to the 3′ end of a precursor RNA to produce the template RNA.
